PureCycle Technologies, Inc.

NasdaqCM:PCT Stock Report

Mkt Cap: US$1.4b

We’ve recently updated our valuation analysis.

PureCycle Technologies Valuation

Is PCT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PCT?

Other financial metrics that can be useful for relative valuation.

PCT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDA-18.7x
PEG Ration/a

Price to Book Ratio vs Peers

How does PCT's PB Ratio compare to its peers?

The above table shows the PB ratio for PCT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average1.9x
KRO Kronos Worldwide
1.5xn/aUS$1.3b
MATV Mativ Holdings
1.3x67.8%US$1.5b
OEC Orion Engineered Carbons
3x22.7%US$1.3b
ASIX AdvanSix
1.7x-0.1%US$1.2b
PCT PureCycle Technologies
2.6x42.4%US$1.4b

Price-To-Book vs Peers: PCT is expensive based on its Price-To-Book Ratio (2.6x) compared to the peer average (1.9x).


Price to Earnings Ratio vs Industry

How does PCT's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.6%
n/an/an/a

Price-To-Book vs Industry: PCT is expensive based on its Price-To-Book Ratio (2.6x) compared to the US Chemicals industry average (2.1x)


Price to Book Ratio vs Fair Ratio

What is PCT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PCT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio2.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate PCT's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of PCT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PCT ($8.38) is trading below our estimate of fair value ($22.5)

Significantly Below Fair Value: PCT is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PCT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$8.38
US$13.50
+61.1%
11.1%US$15.00US$11.00n/a6
Jan ’24US$6.76
US$13.50
+99.7%
11.1%US$15.00US$11.00n/a6
Dec ’23US$6.18
US$13.50
+118.4%
11.1%US$15.00US$11.00n/a6
Nov ’23US$8.10
US$16.33
+101.6%
12.1%US$20.00US$14.00n/a6
Oct ’23US$8.07
US$16.33
+102.4%
12.1%US$20.00US$14.00n/a6
Sep ’23US$8.73
US$16.60
+90.1%
12.4%US$20.00US$14.00n/a5
Aug ’23US$7.52
US$16.80
+123.4%
11.5%US$20.00US$14.00n/a5
Jul ’23US$7.01
US$19.00
+171.0%
27.5%US$30.00US$14.00n/a6
Jun ’23US$8.66
US$19.00
+119.4%
27.5%US$30.00US$14.00n/a6
May ’23US$7.80
US$21.00
+169.2%
23.7%US$30.00US$16.00n/a6
Apr ’23US$8.00
US$21.00
+162.5%
23.7%US$30.00US$16.00n/a6
Mar ’23US$7.24
US$30.08
+315.5%
22.8%US$45.00US$25.00n/a6
Feb ’23US$6.15
US$30.08
+389.2%
22.8%US$45.00US$25.00US$8.386
Jan ’23US$9.57
US$30.08
+214.4%
22.8%US$45.00US$25.00US$6.766
Dec ’22US$11.67
US$30.08
+157.8%
22.8%US$45.00US$25.00US$6.186
Nov ’22US$13.80
US$34.50
+150.0%
25.3%US$48.00US$25.00US$8.106
Oct ’22US$12.79
US$34.50
+169.7%
25.3%US$48.00US$25.00US$8.076
Sep ’22US$15.46
US$35.20
+127.7%
26.7%US$48.00US$25.00US$8.735
Aug ’22US$14.81
US$37.75
+154.9%
23.4%US$48.00US$28.00US$7.524
Jul ’22US$24.48
US$37.75
+54.2%
23.4%US$48.00US$28.00US$7.014
Jun ’22US$17.61
US$39.00
+121.5%
27.4%US$48.00US$24.00US$8.663
May ’22US$25.82
US$46.50
+80.1%
3.2%US$48.00US$45.00US$7.802
Apr ’22US$25.23
US$48.00
+90.2%
0%US$48.00US$48.00US$8.001

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies